Rivista

The efficacy of CHOEP chemotherapyregimenadministered in association with monoclonalantibody anti-CD52 Alemtuzumab in cutaneous T-celllymphoma (CTCL) and systemic T-celllymphoma with cutaneousinvolvement (PTCL)

Autori: Postorino M, De Santis G, Marchesi F, Provenzano I, Franceschini L, Pupo L, Rizzo M, Giannì L, Gumenyuk S, Tonialini L, Fiorelli E, Renzi D, Zizzari A.

Data: 2013

Ambito di interesse: Ematologia

Rivista: (Abstract) 12th International Congress of MalignantLymphoma, Lugano 2013. HematolOncol 2013; 31 (Suppl. 1): 201–270

Potrebbero interessarti anche:

Rivista 6.089

Thrombolysis and bridging therapy in patients with acute ischemic stroke and Covid-19.

Autori:

Data: 2020

Ambito di interesse: Neurologia/emergenza

Rivista: European Jour of neurology

Leggi dettagli

Rivista 18.15

Reconsidering the role of selective sodium channel blockers in genetic generalized epilepsy.

Autori: Cerulli Irelli E, Morano A, Fanella M, Orlando B, Salamone EM, Giallonardo AT, Di Bonaventura C.

Data: 2021

Ambito di interesse: Epilessia

Rivista: Acta Neurol Scand. 2021 Dec;144(6):647-654

Leggi dettagli

Rivista 10,859

Tighter glycemic control is associated with ADL physical dependency losses in older patients using sulfonylureas or mitiglinides: Results from the DIMORA study

Autori: Abbatecola AM, Bo M, Armellini F, D'Amico F, Desideri G, Falaschi P, Greco A, Guerrini G, Lattanzio F, Volpe C, Paolisso G

Data: 2015

Ambito di interesse: metabolismo, diabete

Rivista: Metabolism

Leggi dettagli

The efficacy of CHOEP chemotherapyregimenadministered in association with monoclonalantibody anti-CD52 Alemtuzumab in cutaneous T-celllymphoma (CTCL) and systemic T-celllymphoma with cutaneousinvolvement (PTCL)

Potrebbero interessarti anche:

Thrombolysis and bridging therapy in patients with acute ischemic stroke and Covid-19.

Reconsidering the role of selective sodium channel blockers in genetic generalized epilepsy.

Tighter glycemic control is associated with ADL physical dependency losses in older patients using sulfonylureas or mitiglinides: Results from the DIMORA study

Cosa fare per